References
Thunnissen PLM, Sizoo W, Hendriks WDH: Safety and efficacy of itraconazole in prevention of fungal infections in neutropenic patients. Netherlands Journal of Medicine 1991, 39: 84–91.
De Beule K, De Doncker P, Cauwenbergh G, Koster M, Legendre R, Blatchford N, Daunas J, Chwetzoff E: The treatment of aspergillosis and aspergilloma with itraconazole: clinical results of an open international study (1982–1987). Mycoses 1988, 31: 476–485.
Boogaerts MA, Verhoef GE, Zachee P, Demuynck H, Verbist L, De Beule K: Antifungal prophylaxis with itraconazole in prolonged neutropenia: correlation with plasma levels. Mycoses 1989, 32, Supplement 1: 103–108.
Dutch Hemato-Oncology Group: Intensive cytotoxic treatment followed by autologous bonemarrow rein fusion for consolidation of remission in patients with acute myelocytic leukemia in first remission. Study protocol HOVON-4, September 1987.
British Society for Antimicrobial Chemotherapy Working Party: Laboratory monitoring of antifungal chemotherapy. Lancet 1991, 337: 1577–1580.
Patterson TF, George D, Miniter P, Andriole VT: The role of fluconazole in the early treatment and prophylaxis of experimental Aspergillosis. Journal of Infectious Diseases 1991, 164: 575–580.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
van der Hoven, B., Hendriks, W.D.H. & Sizoo, W. Possible failure of itraconazole in preventing fungal infection in a neutropenic leukaemia patient. Eur. J. Clin. Microbiol. Infect. Dis. 11, 202–204 (1992). https://doi.org/10.1007/BF01967083
Issue Date:
DOI: https://doi.org/10.1007/BF01967083